Stella ms
Research skills
-
TechnicalTwo-dimensional electrophoresis (BioRad, MALDI TOF/TOF MS (Bruker, Westernblotting (ECL and WesternDots, IHC, HPLC (Ultimate, Waters
-
ITFlex Control, FlexAnalysis, ProteinScape, Biotools (Bruker, Mascot, Mascot Deamon, Chromeleon, Xcalibur, PDQuest, QuantityOne, Trans-Proteomics Pipeline, MaxQuant, Office Package, Adobe Photoshop, Reference Manager, Endnote, ALIDA software., Prometheus
-
StatisticalSTATISTICA, SigmaPlot, GPI anchor predictors, GeneMANIA, VisAnt, ProteinProphet
Research interests
-
InterestsLiver Cancer, Phosphoproteomics, Chromatography, Electrophoresis, Mass Spectrometry, Proteomics, clinical validation, Mouse Models, Protein Characterization, Protein Purification, Protein Chemistry, Western Blot, Protein, Protein Purification Techniques, Peptide
Research experience
-
Jan 2011
Research: PostDoc
University of Dundee · MRC PPU · University of DundeeMass Spectrometry · DundeeUltrafleXtreme, Orbitrap Classic, Orbitrap VelosPro, AmaZon, Ultimate 3000, HPLC, MALDI MS, Cell Biology, Cell culture, Western blot, Phosphorylation, Ubiquitylation -
May 2010–
Dec 2010Research: Research Fellow
Fraunhofer ITEM · Molecular toxicology · Fraunhofer ITEMProteomics · HannoverMALDI MS, LC-MALDI, HPLC,2DE, WBs, IHC, chromatography, cell culture, Glycoproteomics, HCC, mouse model -
Apr 2006–
Apr 2010Research: PhD
MHH-Fraunhofer ITEM · Molecular Medicine and Medical Biotechnology · MHH-Fraunhofer ITEMProteomics · HannoverMALDI MS, ESI MS, 2DE, WB, IHC, cell culture, chromatography -
Sep 2004–
Mar 2005Research: microRNA study for Alzheimer disease
CSAN, University "La Sapienza" · CSAN, University "La Sapienza"Nucleic acids · RomeNorthern blotting, PC12 cells, NGF, 32P radiolabelling -
Apr 2004–
Aug 2004Research: Aflatoxins, Quality Control
Istituto Superiore di Sanitá · OGM and mycotoxins · Istituto Superiore di SanitáHPLC quality control · RomeHPLC, Aflatoxins, ocratoxins, Waters, Gilson, Jasco -
Sep 2003–
Jan 2004Research: University scholarship
University "La Sapienza" · Chimica farmaceutica · University "La Sapienza"Analisi dei Medicinali II · Romequantitative analysis
Awards & achievements
-
Feb 2006Award: Leonardo da Vinci Program Grant
Other
-
LanguagesItalian (mother tongue), English, German, Spanish
Publications
-
5.13Impact points
Combined serum and tissue proteomic study applied to a c-Myc transgenic mouse model of hepatocellular carcinoma identified novel disease regulated proteins suitable for diagnosis and therapeutic intervention strategies.
Journal of proteome research. 06/2011; 10(7):3012-30.
Hepatocellular carcinoma (HCC) is the third leading cause of cancer death in the U.S. Notably, most HCCs display c-Myc hyperactivity but this transcription factor participates in the regulation of as many as 15-20% of genes of the human genome. To better understand its oncogenic activity, a mass spe... [more] Hepatocellular carcinoma (HCC) is the third leading cause of cancer death in the U.S. Notably, most HCCs display c-Myc hyperactivity but this transcription factor participates in the regulation of as many as 15-20% of genes of the human genome. To better understand its oncogenic activity, a mass spectrometry-based proteomic approach was employed to search for disease-regulated proteins in liver tissue and serum of c-Myc transgenic mice that specifically developed HCC. Overall, a total of 90 differentially expressed proteins were identified with retinol binding protein 4, transthyretin, major urinary protein family, apolipoprotein E, and glutathione peroxidase being regulated in common in tissue and serum of HCC mice. Importantly, this study identified n = 22 novel tumor tissue-regulated proteins to function in cell cycle and proliferation, nucleotide and ribosomal biogenesis, oxidative stress, and GSH metabolism, while bioinformatics revealed the coding sequences of regulated proteins to enharbour c-Myc binding sites. Translation of the findings to human disease was achieved by Western immunoblotting of serum proteins and by immunohistochemistry of human HCC. Taken collectively, our study helps to define a c-Myc proteome suitable for diagnostic and possible therapeutic intervention strategies.
Following (41)
-
Ciacu Nicoleta
"Constantin Brâncoveanu" University of Piteşti -
Wagner Fontes
Universidade de Brasília -
Deepak Mishra
Reseapro Scientific Services Pvt. Ltd. -
Giuseppe Vecchio
Istituto Italiano di Tecnologia (IIT) -
Paola Di Bonito
Istituto Superiore di Sanità